Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study | |
Fei, Xiaoming[1]; Lei, Fang[2]; Zhang, Haifeng[3]; Lu, Hua[4]; Zhu, Yan[5]; Tang, Yu[6] | |
刊名 | SUPPORTIVE CARE IN CANCER |
2016 | |
卷号 | 24期号:6页码:2727-2733 |
关键词 | Hematological malignancies Adverse events Chemotherapy Risk factor Logistic risk predictive model |
ISSN号 | 0941-4355 |
DOI | http://dx.doi.org/10.1007/s00520-016-3085-6 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000374983300040 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5373334 |
专题 | 江苏大学 |
作者单位 | 1.[1]Jiangsu Univ, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China. 2.Jiangsu Univ, Hematol Res Inst, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China. 3.[2]Jiangsu Univ, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China. 4.[3]Nanjing Med Univ, Affiliated Hosp 1, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China. 5.[4]Nanjing Med Univ, Affiliated Hosp 1, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China. 6.[5]Jiangsu Univ, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China. 7.[6]Jiangsu Univ, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212001, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Fei, Xiaoming[1],Lei, Fang[2],Zhang, Haifeng[3],et al. Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study[J]. SUPPORTIVE CARE IN CANCER,2016,24(6):2727-2733. |
APA | Fei, Xiaoming[1],Lei, Fang[2],Zhang, Haifeng[3],Lu, Hua[4],Zhu, Yan[5],&Tang, Yu[6].(2016).Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study.SUPPORTIVE CARE IN CANCER,24(6),2727-2733. |
MLA | Fei, Xiaoming[1],et al."Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study".SUPPORTIVE CARE IN CANCER 24.6(2016):2727-2733. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论